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Background: Although favorable 12-month clinical outcomes have been reported in the OLIVE Registry after endovascular therapy (EVT) 
in patients with critical limb ischemia (CLI) from infrainguinal disease, 3-year follow-up results are unknown.
methods:  This study was a prospective multicenter (19 sites) registry that consecutively enrolled 312 patients who received infrainguinal 
EVT for CLI. In addition to the 12-month results previously reported, medium-term results up to 3 years were analyzed. Primary outcome 
measure was 3-year amputation-free survival (AFS), while secondary outcome measures were freedom from major adverse limb event 
(MALE) and ulcer recurrence. Prognostic predictors for each outcome were also elucidated by Cox proportional hazard regression analysis 
or the log-rank test.
results:  Diabetic and regular dialysis patients were 71% and 52%, respectively. 82% of the patients had ischemic wounds, and of these 
15% had wound infection. The completion rate of three-year follow-up was 95%. Three-year AFS and freedom from MALE rates were, 
66%, and 84%, respectively. Wound recurrence after one year was 22%. Multivariate analysis revealed age (hazard ratio [HR]: 1.43, 
p=0.001), body mass index (BMI)<18.5 (HR: 2.17, p=0.001), chronic dialysis (HR: 2.91, p<0.001) and Rutherford 6 (HR: 1.64, p=0.0047) 
as 3-year AFS predictors and statin (HR: 0.28, p=0.02), Rutherford 6 (HR: 2.40, p=0.02), one straight line to foot (HR: 0.27, p=0.001) 
and history of heart failure (HR: 1.96, p=0.04) as 3-year MALE predictors, whereas no predictors for wound recurrence were employed. 
Freedom from re-intervention free rate at 1, 2, and 3 years was 60.7%, 51.2%, and 43.2%, respectively. Wound-free survival at 1, 2 and 3 
year was 58.9, 54.8 and 49.6%, respectively.
conclusion:  In CLI patients with infrainguinal lesions, the 3-year clinical results of EVT were satisfactory despite a high re-intervention 
rate and moderate ulcer recurrence rate.
